
Polygalacic acid
CAS No. 22338-71-2
Polygalacic acid( —— )
Catalog No. M18257 CAS No. 22338-71-2
Polygalacic acid(PA) significantly improves cholinergic system reactivity, as indicated by decreased acetylcholinesterase (AChE) activity.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 58 | In Stock |
![]() ![]() |
5MG | 104 | In Stock |
![]() ![]() |
100MG | Get Quote | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NamePolygalacic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionPolygalacic acid(PA) significantly improves cholinergic system reactivity, as indicated by decreased acetylcholinesterase (AChE) activity.
-
DescriptionPolygalacic acid(PA) significantly improves cholinergic system reactivity, as indicated by decreased acetylcholinesterase (AChE) activity, increases choline acetyltransferase (ChAT) activity, and elevates levels of acetylcholine (ACh) in the hippocampus and frontal cortex, PA also significantly ameliorates neuroinflammation and oxidative stress in mice; suggest that PA might exert a significant neuroprotective effect on cognitive impairment, driven in part by the modulation of cholinergic activity and neuroinflammation. Polygalacic acid shows significant postingestive effects on Spodoptera littoralis larvae.
-
In VitroPolygalacic acid (0-100 μM; 24 hours) significantly decreases the mRNA expressions of MMP-3, MMP-9, MMP-13, and COX-2, which are significantly increased by IL-1β, in a dose-dependent manner.Polygalacic acid (0-100 μM; 6 hours) decreases the expression of phosphor-p38, phosphor-Erk, and phosphor-Jnk induced by IL-1β, phosphor-p65 is not reduced by polygalacic acid. RT-PCR Cell Line:Chondrocyte cells Concentration:50 μM; 100 μM Incubation Time:24 hours Result:Suppressed IL-1β-induced COX-2, MMP3, MMP9, and MMP13 mRNA expression.Western Blot Analysis Cell Line:Chondrocyte cells Concentration:50 μM; 100 μM Incubation Time:6 hours Result:Inhibited the IL-1β-induced activation of the MAPK pathway in chondrocytes.
-
In Vivo——
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetLipoxygenase
-
RecptorAChR
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number22338-71-2
-
Formula Weight504.7
-
Molecular FormulaC30H48O6
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (99.07 mM)
-
SMILESO=C(O)[C@]53CCC(C)(C)C[C@H]5C4=CC[C@H]2[C@@](C)(CC[C@@H]1[C@]2(C)C[C@H](O)[C@H](O)[C@@]1(C)CO)[C@]4(C)C[C@H]3O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Choi YH1, Yoo DS, Cha MR, Choi CW, Kim YS, Choi SU, Lee KR, Ryu SY. J Nat Prod. 2010 Nov 29;73(11)
molnova catalog



related products
-
1-Naphthyl 3,5-dinit...
1-Naphthyl 3,5-dinitrobenzoate is an inhibitor of 5-LOX can be used in studies about inflammatory therapy.
-
CAY10698
CAY10698 is a 12-lipoxygenase inhibitor (12-LO; IC50 of 5.1 μM).
-
CJ-13610
CJ-13610 is a potent 5-Lipoxygenase (5-LO) inhibitor that suppresses 5-LO product formation with IC50 of 70 nM.